KRYS
Krystal Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$336.67
−0.61%Forward multiples
Based on analyst estimates
- P/E forward
- 39.80x
- P/E 2026E
- 43.99x
- P/E 2027E
- 35.50x
- P/E 2028E
- 22.40x
- P/S forward
- 17.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- 40.71x
- PEG TTM
- 17.81x
- Price / book
- 7.33x
- Price / sales
- 22.62x
- Price / cash flow
- 36.59x
Enterprise value
- Enterprise value
- $9.1B
- EV / sales
- 20.72x
- EV / EBITDA
- 41.79x
- EV / EBIT
- 46.12x
- Market cap
- $10.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026